562 related articles for article (PubMed ID: 23929039)
1. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
2. Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.
Bandapalli OR; Macher-Goeppinger S; Schirmacher P; Brand K
Clin Exp Metastasis; 2012 Jun; 29(5):409-17. PubMed ID: 22362252
[TBL] [Abstract][Full Text] [Related]
3. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.
Lee JI; Wright JH; Johnson MM; Bauer RL; Sorg K; Yuen S; Hayes BJ; Nguyen L; Riehle KJ; Campbell JS
Am J Physiol Cell Physiol; 2016 Mar; 310(6):C436-45. PubMed ID: 26632601
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
Campbell JS; Hughes SD; Gilbertson DG; Palmer TE; Holdren MS; Haran AC; Odell MM; Bauer RL; Ren HP; Haugen HS; Yeh MM; Fausto N
Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3389-94. PubMed ID: 15728360
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
[TBL] [Abstract][Full Text] [Related]
7. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
[TBL] [Abstract][Full Text] [Related]
8. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
[TBL] [Abstract][Full Text] [Related]
9. Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development.
Okada H; Honda M; Campbell JS; Sakai Y; Yamashita T; Takebuchi Y; Hada K; Shirasaki T; Takabatake R; Nakamura M; Sunagozaka H; Tanaka T; Fausto N; Kaneko S
Cancer Res; 2012 Sep; 72(17):4459-71. PubMed ID: 22651928
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
13. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
[TBL] [Abstract][Full Text] [Related]
14. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
17. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
18. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
20. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29.
Kwiecinski M; Elfimova N; Noetel A; Töx U; Steffen HM; Hacker U; Nischt R; Dienes HP; Odenthal M
Lab Invest; 2012 Jul; 92(7):978-87. PubMed ID: 22565577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
